114 related articles for article (PubMed ID: 18930545)
1. [Value of perfusion MRI in the study of pilocytic astrocytoma and hemangioblastoma: preliminary findings].
Bing F; Kremer S; Lamalle L; Chabardes S; Ashraf A; Pasquier B; Le Bas JF; Krainik A; Grand S
J Neuroradiol; 2009 May; 36(2):82-7. PubMed ID: 18930545
[TBL] [Abstract][Full Text] [Related]
2. Perfusion-sensitive MRI of pilocytic astrocytomas: initial results.
Grand SD; Kremer S; Tropres IM; Hoffmann DM; Chabardes SJ; Lefournier V; Berger FR; Pasteris C; Krainik A; Pasquier BM; Peoch M; Le Bas JF
Neuroradiology; 2007 Jul; 49(7):545-50. PubMed ID: 17530237
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of hemangioblastomas from pilocytic astrocytomas using 3-T magnetic resonance perfusion-weighted imaging and MR spectroscopy.
She DJ; Xing Z; Zeng Z; Shang XY; Cao DR
Neuroradiology; 2015 Mar; 57(3):275-81. PubMed ID: 25487356
[TBL] [Abstract][Full Text] [Related]
4. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
[TBL] [Abstract][Full Text] [Related]
5. Cerebral pilocytic astrocytoma with spontaneous intracranial hemorrhage in adults.
Li HM; Hsu SS; Wang JS; Weng MJ; Fu JH; Chen CK; Lai PH
J Chin Med Assoc; 2008 Nov; 71(11):587-93. PubMed ID: 19015059
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of pilocytic astrocytoma, medulloblastoma, and hemangioblastoma on diffusion-weighted and dynamic susceptibility contrast perfusion MRI.
Kurokawa R; Kurokawa M; Baba A; Kim J; Capizzano A; Bapuraj J; Srinivasan A; Moritani T
Medicine (Baltimore); 2022 Nov; 101(44):e31708. PubMed ID: 36343086
[TBL] [Abstract][Full Text] [Related]
7. Combined value of susceptibility-weighted and perfusion-weighted imaging in assessing who grade for brain astrocytomas.
Wang XC; Zhang H; Tan Y; Qin JB; Wu XF; Wang L; Zhang L
J Magn Reson Imaging; 2014 Jun; 39(6):1569-74. PubMed ID: 24987755
[TBL] [Abstract][Full Text] [Related]
8. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
[TBL] [Abstract][Full Text] [Related]
9. Spinal hemangioblastoma combined with pilocytic astrocytoma.
Li WQ; Wang X; Zhong NZ; Li YM
Neurosciences (Riyadh); 2015 Jul; 20(3):280-4. PubMed ID: 26166599
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance dynamic susceptibility-weighted contrast-enhanced perfusion imaging in the diagnosis of posterior fossa hemangioblastomas and pilocytic astrocytomas: initial results.
Kumar VA; Knopp EA; Zagzag D
J Comput Assist Tomogr; 2010; 34(6):825-9. PubMed ID: 21084895
[TBL] [Abstract][Full Text] [Related]
11. MR dynamic-susceptibility-contrast perfusion metrics in the presurgical discrimination of adult solitary intra-axial cerebellar tumors.
Pons-Escoda A; Garcia-Ruiz A; Garcia-Hidalgo C; Gil-Solsona R; Naval-Baudin P; Martin-Noguerol T; Fernandez-Coello A; Flores-Casaperalta S; Fernandez-Viñas M; Gago-Ferrero P; Oleaga L; Perez-Lopez R; Majos C
Eur Radiol; 2023 Dec; 33(12):9120-9129. PubMed ID: 37439938
[TBL] [Abstract][Full Text] [Related]
12. Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence.
Fuss M; Wenz F; Scholdei R; Essig M; Debus J; Knopp MV; Wannenmacher M
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):53-8. PubMed ID: 10924971
[TBL] [Abstract][Full Text] [Related]
13. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas.
Young R; Babb J; Law M; Pollack E; Johnson G
J Magn Reson Imaging; 2007 Oct; 26(4):1053-63. PubMed ID: 17896374
[TBL] [Abstract][Full Text] [Related]
14. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
Thomsen H; Steffensen E; Larsson EM
Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
[TBL] [Abstract][Full Text] [Related]
15. [Perfusion magnetic resonance imaging for high grade astrocytomas: Can cerebral blood volume, peak height, and percentage of signal intensity recovery distinguish between progression and pseudoprogression?].
Martínez-Martínez A; Martínez-Bosch J
Radiologia; 2014; 56(1):35-43. PubMed ID: 23790618
[TBL] [Abstract][Full Text] [Related]
16. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ
Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner.
Sentürk S; Oğuz KK; Cila A
Diagn Interv Radiol; 2009 Mar; 15(1):3-12. PubMed ID: 19263367
[TBL] [Abstract][Full Text] [Related]
18. Use of dynamic susceptibility-contrast MRI (DSC-MRI) to assess perfusion changes in the ipsilateral brain parenchyma from glioblastoma.
Ulmer S; Liess C; Kesari S; Otto N; Straube T; Jansen O
J Neurooncol; 2009 Jan; 91(2):213-20. PubMed ID: 18807224
[TBL] [Abstract][Full Text] [Related]
19. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.
Knopp EA; Cha S; Johnson G; Mazumdar A; Golfinos JG; Zagzag D; Miller DC; Kelly PJ; Kricheff II
Radiology; 1999 Jun; 211(3):791-8. PubMed ID: 10352608
[TBL] [Abstract][Full Text] [Related]
20. [Perfusion MR imaging for initial diagnosis and follow-up of brain tumors].
Le Bas JF; Grand S; Kremer S; Tropres I; Jiang Z; Krainik A; Remy C; Berger F; Benabid AL
Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):287-98. PubMed ID: 16292173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
